M&A Deal Summary |
|
|---|---|
| Date | 2021-11-04 |
| Target | Plasti-Fab |
| Sector | Building Materials |
| Buyer(s) | Riverside |
| Deal Type | Going Private |
| Deal Value | 178M USD |
| Advisor(s) | Intrepid Investment Bankers (Financial) Burnet, Duckworth & Palmer (Legal) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 5.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
The Riverside Company is a global private equity firm that seeks investments in profitable lower middle-market companies valued under $400 million. Riverside looks to invest in growth businesses headquartered in North America, Europe, and Asia (primarily Japan and South Korea), that have been in operation for at least five years. Riverside targets investments in a wide array of industries including distribution, automotive, healthcare, education, manufacturing, software, consumer services, plastics, publishing, food, communications, marine, and business services. Riverside was formed in 1988 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 267 of 295 |
| Sector: Building Materials M&A | 9 of 9 |
| Type: Going Private M&A Deals | 2 of 2 |
| State: Alberta M&A | 1 of 1 |
| Country: Canada M&A | 7 of 8 |
| Year: 2021 M&A | 11 of 14 |
| Size (of disclosed) | 2 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-10-26 |
Actineo
Cologne, Germany Actineo specializes in bodily injury claims, providing tech-enabled and data-driven services to the insurance industry. The Company processes and digitalizes more than 120,000 bodily injury claims per year and develops prediction models for a customer base of more than 50 insurers. Customers benefit from increased transparency, control, and better risk management. Actineo was founded in 2009 and is based in Cologne, Germany. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-09 |
Avance Clinical
Firle, Australia Avance Clinical is a Contract Research Organization (CRO) for international biotechs. CRO has been delivering clinical drug development services for international biotechs for FDA and EMA regulatory approval, for the past 24 years. Avance Clinical was founded in 2019 and is based in Firle, Australia. |
Buy | - |
